SAO PAULO (Reuters) - Brazilian drug and medical products distributor Viveo has priced its initial public offering (IPO) at 19.92 reais per share, at the bottom of the suggested price range, the company said in a securities filing. The IPO valued Viveo at 5.7 billion reais ($1.1 billion. The company and its shareholders raised 2.32 billion reais in the offering. Shares will begin trading on Monday in Brazil’s B3 SA Bolsa Brasil Balcao under the ticker VVEO3. ($1 = 5.2280 reais) Reporting by Paula Laier; Editing by Mark Potter Our Standards: The Thomson Reuters Trust Principles.